Haemonetics Corp/ US4050241003 /
| 2024-04-18 10:10:00 PM | Chg. -1.42 | Volume | Bid12:48:07 AM | Ask12:48:07 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 83.46USD | -1.67% | 966,385 Turnover: 69.52 mill. |
50.00Bid Size: 100 | 87.82Ask Size: 100 | 4.24 bill.USD | - | 36.77 |
Assets
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 332.1560 | 343.9790 | 253.3990 | 217.5590 | 258.4820 | ||||||
| Intangible Assets | 156.5890 | 127.6930 | 133.1060 | 365.4830 | 310.2610 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 716.1620 | 698.6460 | 663.4710 | 1,126.3770 | 1,103.7030 | ||||||
| Inventories | 160.7990 | 194.3370 | 270.2760 | 322.6140 | 293.0270 | ||||||
| Accounts Receivable | 151.2260 | 185.0270 | 165.2070 | 127.5550 | 159.3760 | ||||||
| Cash and Cash Equivalents | 180.1690 | 169.3510 | 137.3110 | 192.3050 | 259.4960 | ||||||
| Current Assets | 521.1770 | 576.1210 | 603.6390 | 693.5460 | 756.0310 | ||||||
| Total Assets | 1,237.3390 | 1,274.7670 | 1,267.1100 | 1,819.9230 | 1,859.7340 | ||||||
Liabilities
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 55.2650 | 63.3610 | 50.7300 | 50.2930 | 58.3710 | ||||||
| Long-term debt | 59.4230 | 322.4540 | 305.5130 | 690.5920 | 559.4410 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 6.5000 | 19.9000 | 10.6000 | - | - | ||||||
| Liabilities | 484.9100 | 606.8990 | 680.0010 | 1,088.2530 | 1,110.3100 | ||||||
| Share Capital | .5230 | .5100 | .5030 | .5090 | .5110 | ||||||
| Total Equity | 752.4290 | 667.8680 | 587.1090 | 731.6700 | 749.4240 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 1,237.3390 | 1,274.7670 | 1,267.1100 | 1,819.9230 | 1,859.7340 | ||||||
Income Statement
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 903.9230 | 967.5790 | 988.4790 | 870.4630 | 993.1960 | ||||||
| Depreciation (total) | 89.2470 | 109.4180 | 110.2890 | 84.2870 | 97.7470 | ||||||
| Operating Result | 56.1570 | 83.5450 | 103.3510 | 89.7470 | 80.7500 | ||||||
| Interest Income | -4.5250 | -9.9120 | -16.1990 | -16.8340 | -17.1210 | ||||||
| Income Before Taxes | 59.6320 | 73.6330 | 87.1520 | 72.9130 | 63.6290 | ||||||
| Income Taxes | 14.0600 | 18.6140 | 10.6000 | -6.6000 | 20.3000 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 45.5720 | 55.0190 | 76.5260 | 79.4690 | 43.3750 | ||||||
Per Share
Cash Flow
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 220.3500 | 159.2810 | 158.2170 | 108.8050 | 172.2630 | ||||||
| Cash Flow from Investing Activities | -63.0410 | -116.1480 | -57.1760 | -425.4420 | -86.3450 | ||||||
| Cash Flow from Financing | -120.6430 | -50.6280 | -131.2080 | 367.4520 | -15.7490 | ||||||
| Decrease / Increase in Cash | 40.6050 | -10.8180 | -32.0400 | 54.9940 | 67.1910 | ||||||
| Employees | 3,136 | 3,216 | 3,004 | - | - | ||||||
